• Advising an A-share listed medical device company in a series of acquisitions of US-based medical device companies
  • Advising a major Chinese investment firm affiliated to Shanghai municipal government in the US$400 million Series F financing for Mobileye N.V.
  • Advising a leading Chinese airline company in its US$450 million strategic alliance with a leading US airline company as well as multiple issuances of dim sum bonds
  • Advising a US Fortune100 company in the acquisition of a Singapore-based multinational company
  • Advising a US Fortune100 company in its strategic alliances with a number of major state-owned Chinese companies
  • Advising a major US chemical company in its acquisition of a Taiwan chemical company
  • Advising a major US private equity fund in its purchase, financing, refinancing and disposal of a block of high-end residential apartments in Macao
  • Advising an European real estate investment fund in the acquisition, financing, refinancing and disposal of a series of real estate projects in various parts of China
  • Advising a major US multinational company with a household name in a series of purchases and dispositions of China-based business assets
  • Advising a major European bank in its lease financing of a major recreational facility in Beijing.
  • Advising a multilateral organization in its acquisition of a stake in a major Chinese bank
  • Advising a formerly state-owned Chinese company controlled by its management on its initial public offering of shares on the Hong Kong Stock Exchange
  • Advising a leading US beer manufacturer on its strategic alliance with a leading Chinese beer manufacturer listed on the Hong Kong Stock Exchange